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Aim:
 
 Whether timing of catheterization (immediate versus delayed inter-
vention) in high risk ACS has an impact on outcome in patients with RF is not
known.
 
Methods:
 
 In the randomized ABOARD study we showed that in patients
with NSTE-ACS, a  “primary PCI” strategy compared with a strategy of inter-
vention deferred to the next working day did not result in a difference of clin-
ical outcome. We compared these two strategies according to the renal status
at 1-month follow-up. Severe RF was defined by a Creatinin Clearance (CrCl)
30 ml/min and moderate RF by a CrCl >30 and  60 ml/min 
 
Results:
 
 Eight (2.3%) patients had severe RF, 67 (19.4%) moderate RF and
270 (78.3%) no RF. Baseline characteristics were well matched except for a
lower multivessel disease rate in the “primary PCI” strategy group (52% vs
85%, p=0.008) in the moderate RF group. Patients received intense antiplatelet
therapy with a mean 660 mg (±268) clopidogrel loading dose followed by a
111 mg (±40) maintenance dose, while 99% of the PCI patients received
abciximab. LMWH were used in 68% of patients and radial approach was pre-
dominant (84%). The mean peak of troponin did not differ according to the
revascularization strategy wathever the renal function. The 30-day rate of
death, MI and urgent revascularization were higher in RF patients but did not
differ significantly between the two revascularization strategies whatever the
renal function. Recurrent ischemia was however significantly more frequent in
the moderate RF group undergoing deferred catheterization in comparison
with a primary PCI strategy (33,3% vs. 8.8%, p= 0.014). Major bleeding com-
plications were similar whatever the strategy in the different renal function
groups. 
 
Conclusion: 
 
Although renal failure is associated with more ischemic com-
plications, the timing of intervention appears to have no impact on outcome of
these patients. Thus, the primary results of the ABOARD study apply also to
renal failure patients. 
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Purpose:
 
 Recent improvement in management of), and notably reduction
of delays to coronary reperfusion, allowed a decrease of the incidence of
ischemic. Moreover, (CAD) are more and more accessible. This study aims at
determining the actual epidemiology and intra-hospital prognosis of ST-Eleva-
tion Myocardial Infarction (STEMI) complicated by cardiogenic shock (CS)
requiring circulatory assist device (CAD).
 
Methods:
 
 We analyzed data collected between June 06 and September 09
in the “Observatoire Régional Breton sur l’Infarctus (ORBI)”, a registry of all
patients admitted to an interventional cardiology centre of Brittany in the acute
phase of a STEMI, within 24 h of symptoms onset. Main clinical data and
intra hospital outcome were compared between ORBI patients requiring CAD
for CS (group 1) and those who didn’t require CAD (group 2).
 
Results:
 
 Among 2700 patients included in the ORBI registry, 101 patients
(3.7 %) required CAD: intra aortic balloon pump (IABP), 93 patients (3.4 %),
extra corporal life support (ECLS), 2 patients (0.07%), IABP and ECLS, 6
patients (0.2%). Main clinical data are summarized in table 1. Group 1 mor-
tality was high (38%), compared to the low mortality in group 2 (4%,
p<0.0001). Mean length of hospitalisation was significantly higher in the
group 1 than in the group 2 (respectively 8.9 ± 7 and 6.7 ± 4 days, p=0.03).
Factors associated with CAD requiring were: age, anterior area STEMI, coro-
nary angioplasty, three-vessel or left main coronary artery disease and haemo-
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Table 1 (abstract 330).
 n Group 1
n = 101
Group 2
n = 2599
p Group 1
deceased
patients
n = 38
Group 1
alive
patients
n = 63
p
Patients
Age (years)
Male
Hypertension
Diabetes
Curent smoker
Prior myorcardial infection
65,7 ± 12
76 (75 %)
47 (47 %)
18 (18%)
26 (27 %)
9 (9%)
62,6 ± 13
1998 (77 %)
1051 (40 %)
383 (15 %)
959 (37 %)
202 (8 %)
0,02
0,72
0,21
0,39
0,05
0,2
69,4 ± 9
28 (74 %)
15 (40 %)
7 (19 %)
6 (17 %)
1 (3 %)
63,4 ± 13
48 (76 %)
32 (51 %)
11 (17 %)
20 (33 %)
8 (13 %)
0,01
0,8
0,4
1,0
0,1
0,2
STEMI
Anterior area
Mean delay* (minutes)
Thrombolysis prior to admission
Coronary angioplasty
Thress-vessel or left main coronary artery disease
71 (70%)
241,9 ± 221
12 (12 %)
96 (95 %)
37 (37 %)
1104 (57 %)
261,9 ± 243
485 (19 %)
2244 (86 %)
418 (17 %)
< 0,0001
0,51
0,09
0,01
< 0,0001
24 (63 %)
243 ± 221
4 (10%)
36 (95 %)
22 (58 %) 
47 (75 %)
241 ± 228
8 (13 %)
60 (95 %)
15 (24 %)
0,03
0,7
1,0
1,0
< 0,0001
Hermondynamic
Heart rate at the admission (/min)
Blood pressure at the admission (nmHg)
Grade 3 and 4 Kilip at the admission
Left ventricular ejection fraction
81,9 ± 25
108,0 ± 32
41 (43 %)
37,3 ± 12
76,1 ± 18
132,3 ±26
108 (4 %)
50,9 ± 10
0,02
< 0,0001
< 0,0001
< 0,0001
85,9 ± 31
95,2 ± 30
24 (71 %)
31,7 ± 12
79,5 ± 22
115,7 ± 32
17 (28 %)
40,6 ± 9
0,3
0,02
< 0,0001
< 0,0001
* Mean delay is mean delay between onset of symptoms ans admission in the international cardiology centre ST-Elevation Myocardial infarction
Group 1 : « Circulatory Assist Device requing », Group 2 : « Non circulatory Assist Device requing 
